Clozapine Tablet
NDC 72603-911
Product Information
Clozapine is a ANDA-approved product labeled by Northstar Rx Llc. See also Warning section. It is supplied as a yellow tablet for oral administration. This product entry covers the primary NDC 72603-911 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
C;C;54
Code Structure Chart
Product Details
What is NDC 72603-911?
What are the uses of this product?
What are Active Ingredients of this product?
- CLOZAPINE 25 mg/1 - A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLOZAPINE (UNII: J60AR2IKIC)
- CLOZAPINE (UNII: J60AR2IKIC) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STARCH, CORN (UNII: O8232NY3SJ)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POVIDONE K30 (UNII: U725QWY32X)
- TALC (UNII: 7SEV7J4R1U)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.